Resultados de la búsqueda 651-660 of 3838 for forgiveness andhealth

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

  2. Mayo Clinic

    Por tanto, la terapia de protones evita efectos secundarios nocivos y debilitantes en los tejidos sanos de alrededor. El barrido con haz filiforme de intensidad ...

  3. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate whether proton radiation therapy (proton RT) reduces acute gastrointestinal toxicities at the end of treatment compared ...

  6. Oncología (médica) - Ensayos clínicos

    A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...

  7. Mayo Clinic

    Share · Tweet. Ver también. Absceso dental · Agammaglobulinemia ligada al cromosoma X · Anafilaxia · Anorgasmia en mujeres · Asma infantil · Ataxia ...

  8. Salud del adulto Maintaining good health - Mayo Clinic

    Office of Disease Prevention and Health Promotion. https://health.gov/myhealthfinder/doctor-visits/screening-tests. Accessed May 23, 2023. Unintentional ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Chemotherapy drugs, such as cisplatin, carboplatin, and gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

  10. Oncología (médica) - Ensayos clínicos

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...